Smallpox vaccine - SIGA
Latest Information Update: 23 Sep 2014
At a glance
- Originator SIGA Technologies
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Smallpox
Most Recent Events
- 31 Dec 2003 Phase-I clinical trials in Smallpox in United Kingdom (unspecified route)
- 19 Aug 2003 Preclinical trials in Smallpox in USA (unspecified route)